Equity Brief · Healthcare2026-05-20
DHR·Healthcare

Danaher Corporation

I · Analiza AI

Pe scurt

Danaher manufactures specialized equipment and supplies that pharmaceutical companies use to develop and produce drugs, particularly biologics like monoclonal antibodies. They also make diagnostic instruments for hospitals and research labs, along with software and consumables that support the entire drug development lifecycle. The company serves customers in over 60 countries through well-known brands like Beckman Coulter, Leica Microsystems, and Pall.

Danaher is a $118 billion healthcare and life sciences conglomerate that makes equipment, chemicals, and software used by pharmaceutical companies and hospitals [Yahoo Finance]. The company operates through three divisions: Biotechnology (equipment for drug manufacturing), Life Sciences (research instruments and genomics tools), and Diagnostics (hospital testing equipment) [Yahoo Finance]. Despite recent stock underperformance, its core bioprocessing business is recovering strongly with equipment orders up 30%+ as pharma companies expand production capacity [Yahoo Finance].

Solid cash generation with moderate leverage, though profitability metrics show room for improvement

Pe scurt AI analysisÎncredere 7/10

Scor Sentinellis

6.3/10

Moderate concerns

Capitalizare bursieră

$118.2B

Venituri (12 luni)

$24.6B

II · Știri recente

Ce a mișcat prețul

6 stories · ranked by relevance

  • macro2026-05-20

    Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?

    Yahoo Finance

  • macro2026-05-20

    Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal

    Simply Wall St

  • macro2026-05-19

    Genedata Introduces AI-Native CMC Platform to Accelerate Drug Development and Manufacturing

    Yahoo Finance

  • macro2026-05-18

    Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading

    Yahoo Finance

  • macro2026-05-18

    Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

    Yahoo Finance

  • macro2026-05-17

    Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks

    Yahoo Finance

Premium · gratuit cu orice cont

The stock has fallen 27% in 2026 following multiple weak quarterly earnings reports, significantly underperforming the S&P 500's 27% gain over the past year [Yahoo Finance]

1 din 5 riscuri din acest raport

Riscuri

5

Oportunități

7

Semnale de alarmă

3

Conducere

10

Încă 24 de constatări în raportul complet — gratuit cu orice cont.

Deblochează analiza completă Danaher Corporation

Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.

  • 5 riscuri, 7 oportunități și 3 semnale de alarmă — fiecare cu sursa lui
  • Peste 100 de indicatori financiari, cu grafice și comparații
  • Rezumate complete ale știrilor, cu linkuri către surse
  • Echipa de conducere și remunerația
  • Export PDF pentru citit offline
Deblochează 15 constatări3 rapoarte gratuite · fără card

III · Companii similare

Ai putea citi și

Same sector · Healthcare or comparable health

Vrei compania asta pe lista ta?

Read three companies free. Fără card.

Primești 3 rapoarte gratuite